Passenger leukocytes and microchimerism: What role in tolerance induction?

Transplantation

Volumn 75, Issue 9 SUPPL., 2003, Pages

  Wood, Kathryn J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; CONFERENCE PAPER; GRAFT REJECTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LEUKOCYTE; LIVER TRANSPLANTATION; MICROCHIMERISM; NONHUMAN; ORGAN TRANSPLANTATION; PASSENGER LEUKOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSPLANTATION;

EID: 0037955553     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000067946.90241.2f     Document Type: Conference Paper

References (35)

1. Hart DNJ, Fabre JW. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not brain. J Exp Med 1981; 153: 347.
2. Larsen C, Morris P, Austyn J. Migration of dendritic leukocytes form cardiac allografts into host spleens: A novel pathway for initiation of rejection. J Exp Med 1990; 171: 307.
3. Banchereau J, Steinman R. Dendritic cells and the control of immunity. Nature 1998; 392: 245.
4. Bishop G, Sun J, DeCruz D, et al. Tolerance to rat liver allografts: III. Donor cell migration and tolerance associated cytokine production in peripheral lymphoid tissues. J Immunol 1996; 156: 4925.
5. Jones N, van Maurik A, Hara M, et al. T cell activation, proliferation and memory after cardiac transplantation in vivo. Ann Surg 1999; 229: 570.
6. + T cells during mouse cardiac allograft rejection. Transplantation 2000; 69: 639.
7. Lakkis F, Arakelov A, Konienczny B, et al. Immunologic 'ignorance' of vascularised organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686.
8. Jones N, Turvey S, Van Maurik A, et al. Differential susceptibility of heart, skin and islet allografts to T cell mediated rejection. J Immunol 2001; 166: 2824.
9. Lafferty K, Cooley M, Woolnough J, et al. Thyroid allograft immunogenicity is reduced after a period of organ culture. Science 1975; 188: 259.
10. Lechler R, Batchelor J. Immunogenicity of retransplanted rat kidney allografts: Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient. J Exp Med 1982; 156: 1835.
11. Lechler RI, Batchelor JR. Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 1982; 155: 31.
12. Goldberg L, Bradley J, Connolly J, et al. Anti-CD45 monoclonal antibody perfusion of human renal allografts prior to transplantation: A safety and immunohistological study. CD45 study group. Transplantation 1995; 59: 1285.
13. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969; 223: 472.
14. Zimmermann FA, Davies HS, Knoll PP, et al. Orthotopic liver allografts in the rat: The influence of strain combination in the fate of the graft. Transplantation 1984; 37: 406.
15. Qian S, Demetris A, Murase N, et al. Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
16. Sriwatanawongsa V, Davies H, Calne R. The essential roles of parenchymal tissues and passenger leukocytes in the tolerance induced by liver grafting in rats. Nat Med 1995; 1: 428.
17. Ko S, Dewick A, Jager M, et al. The functional relevance of passenger leukocytes and microchimerism for heart allograft acceptance in the rat. Nat Med 1999; 5: 1292.
18. Fabre JW, Morris PJ. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation 1972; 14: 608.
19. Wood KJ, Evins J, Morris PJ. Suppression of renal allograft rejection in the rat by class I antigen on purified erythrocytes. Transplantation 1985; 39: 56.
20. Josien R, Heslan M, Brouard S, et al. Critical requirement for graft passenger leukocytes in allograft tolerance induced by donor blood transfusion. Blood 1998; 12: 4539.
21. Dallman MJ, Shiho O, Page TH, et al. Peripheral tolerance to alloantigen results from altered regulation of the interleukin-2 pathway. J Exp Med 1991; 173: 79.
22. Delriviere L, Havaux X, Latinne D, et al. Administration of exogenous interleukin-2 abrogates spontaneous rat liver allograft acceptance but does not affect long-term established graft survival. Transplantation 1997; 63: 1698.
23. Tu Y, Arima T, Flye M. Rejection of spontaneously accepted rat liver allografts with recipient interleukin-2 treatment or donor irradiation. Transplantation 1997; 63: 177.
24. Sharland A, Yan Y, Wang C, et al. Evidence that apoptosis of activated T cells occurs in spontaneous liver graft acceptance and is blocked by manipulations that break tolerance. Transplantation 1999; 68: 1736.
25. Starzl T, Demerits A, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340: 876.
26. Starzl T, Demetris A, Trucco M, et al. Chimerism and donor specific non-reactivity 27 to 29 years after kidney allotransplantation. Transplantation 1993; 55: 1272.
27. Starzl T, Demetris A, Murase N, et al. Donor cell chimerism permitted by immunosuppressive drugs: A new view of organ transplantation. Immunol Today 1993; 14: 326.
28. McSherry C, Jackson A, Hertz M, et al. Sequential measurement of peripheral blood allogeneic chimerism levels and association with pulmonary function. Transplantation 1996; 62: 1811.
29. Schlitt H, Hindrieser J, Hisanaga M. Patterns of donor-type microchimerism after heart transplantation. Lancet 1994; 343: 1469.
30. Schlitt H, Hundrieser J, Ringe B, et al. Donor-type microchimerism associated with graft rejection eight years after liver transplantation. N Engl J Med 1994; 330: 646.
31. Hamano K, Rawsthorne M, Bushell A, et al. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for the maintenance of tolerance to alloantigen in anti-CD4 treated recipients. Transplantation 1996; 62: 856.
32. Elwood E, Larsen C, Maurer D, et al. Microchimerism and rejection in clinical transplantation. Lancet 1997; 349: 1358.
33. Wood K, Sachs D. Chimerism and transplantation tolerance: Cause and effect. Immunol Today 1996; 12: 584.
34. Bushell A, Pearson T, Morris P, et al. Donor recipient microchimerism is not required for tolerance induction following recipient pretreatment with donor specific transfusion and anti-CD4 antibody: Evidence for a clear role for short term antigen persistence. Transplantation 1995; 59: 1367.
35. Scully R, Qin S, Cobbold S, et al. Mechanisms in CD4 antibody-mediated transplantation tolerance: Kinetics of induction, antigen dependency and role of regulatory T cells. Eur J Immunol 1994; 24: 2383.